Global Blood Therapeutics CEO Ted Love: Diversity is our ... Global Blood Therapeutics, Inc. - ] Shares Global Blood Therapeutics, Inc. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT This letter is being delivered to you in connection with the offering by Global Blood Therapeutics, Inc. (the "Company") of [ ] shares of common stock, $0.001 par value (the "Common Stock"), of the Company and the lock-up letter dated , 20 (the . GBT corporate office is located in 181 Oyster Point Blvd, South San Francisco, California, United States and has 576 employees. Global Blood Therapeutics - Wiki - Finpedia This Amended and Restated Cash Incentive Bonus Plan (the "Plan") is intended to provide an annual incentive for superior work and to help motivate eligible employees of Global Blood Therapeutics, Inc. (the "Company") toward even higher achievement and business results, to further tie their goals and interests to those of the Company and its stockholders and to help enable the Company . What is this? Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based . Global Blood Therapeutics (GBT) Follow Following Location: USA " GBT is a biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. Sales Growth. Global Blood Therapeutics General Information: Business: We are a biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. Ex-10.7 - Sec Retaining Employees in the Life Sciences Industry SOUTH SAN FRANCISCO, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT or the Company) (NASDAQ: GBT) today announced that, on January 1, 2019, the compensation committee of the Company's board of directors granted three new employees options to purchase an aggregate of 6,000 shares of the Company's common stock with a per share exercise price of $41.05 and . For cell phone numbers in the U.S., please use the format: +1 xxx . Global Blood Therapeutics Management | Global Blood ... See the company profile for Global Blood Therapeutics, Inc. (GBT) including business summary, industry/sector information, number of employees, business summary, corporate governance, key . SOUTH SAN FRANCISCO, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on March 1, 2021, the compensation committee of GBT's board of directors granted 14 new employees options to purchase an aggregate of 11,525 shares of the company's common stock with a per share exercise price of $44.48 and restricted stock units for an . global blood therapeutics, inc. global blood therapeutics inc. Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. Date Filed: 02/25/2022. This is the Global Blood Therapeutics company profile. However, there's a significant range between the top 10 percent of earners and the bottom 10 percent of earners. Learn more about the sector, industry, classification, employee size, and executives of GBT on MSN Money. Meanwhile . The company's lead product candidate is voxelotor (previously known as GBT440), an oral, once-daily therapy that modulates hemoglobin's affinity . Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Global Blood Therapeutics . Global Blood Therapeutics, Inc. (NASDAQ:GBT) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Investors 5. Message & data rates may apply.) gbt.com. Oxbryta Full Prescribing Information. 87% of employees would recommend working at Global Blood Therapeutics to a friend and 76% have a positive outlook for the business. the compensation committee of GBT's board of directors granted 19 new employees restricted stock units for an aggregate of 42,380 shares of the company's . 201-500 Employees Based in South San Francisco, California Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development, and delivery of life-changing treatments that provide hope to underserved patient communities. The purpose of the Plan is to enable Global Blood Therapeutics, Inc., a Delaware corporation (the "Company"), and its Subsidiaries to grant equity awards to induce highly-qualified prospective officers and employees who are not currently employed by the Company or its Subsidiaries to accept employment and to provide them with a proprietary . . N/A. Founded in 2011, GBT is delivering on its goal to transform the treatment and care of sickle cell disease (SCD), a lifelong, devastating inherited . We're slowly rolling out invites to our waitlist. See insights on GBT (Global Blood Therapeutics) including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. global blood therapeutics, inc. global blood therapeutics inc. ET by Tomi Kilgore. However, the reported number was . Location: South San Francisco, CA. The company was able to report growth for its flagship product, Oxbryta, in the face of COVID-19 headwinds. View Andrea Kim's business profile as Director, Toxicology at Global Blood Therapeutics. GBT Announces New Employment Inducement Grants - Dec 09, 2021. $194.75M. 253 articles with Global Blood Therapeutics . Global Blood Therapeutics: Changing My Strategy After Recent Earnings. Rajiv Patni Chief Medical Officer. South San Francisco, CA: Global Blood Therapeutics, Inc.; 12/2021. Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities. Employee Profiles 16. Global Blood Therapeutics (GBT) is seeking a skilled leader to enhance and optimize the Company's focus on Learning and Development and field execution. Employee may perform other related duties as negotiated to meet the ongoing needs of the organization. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R . In acquiring the two early-stage Sanofi drugs for sickle cell disease, Global Blood Therapeutics aims to complement Oxbryta, its FDA-approved treatment for the rare blood disorder. Executive Medical & Science, Operations 2 emails found 2 phone numbers found . Learn about Global Blood Therapeutics Inc (GBT:XNAS) stock quote with Morningstar's rating and analysis and stay up to date with the current news, price, valuation, dividends and other stock . Forgot Password? Find high paying available jobs at Global Blood Therapeutics.For expert network information on Global Blood Therapeutics compensation and careers, use Ladders $100K + Club. Join our community to chat with employees from Global Blood Therapeutics and many other tech companies. This is a preliminary report on Global Blood Therapeutics's security posture. GBT is a pharmaceutical company that develops and commercializes therapies for the treatment of skin cell diseases. Glassdoor gives you an inside look at what it's like to work at Global Blood Therapeutics, including salaries, reviews, office photos, and more. Global Blood Therapeutics Inc. South San Francisco, CA. The past year was a transformational time for Global Blood Therapeutics. The company recently reported mixed earnings and revealed a hefty cash position. Brian Cathers. Case Number: 20-CA-291328. GBT corporate office is located in 181 Oyster Point Blvd, South San Francisco, California, United States and has 576 employees. Glassdoor has 21 Global Blood Therapeutics reviews submitted anonymously by Global Blood Therapeutics employees. Employees. Global Blood Therapeutics . As an employee at Global Blood Therapeutics in the USA, you can expect to earn an average salary of $47,083 per year, or $22.64 an hour. We are developing our initial product candidate, GBT440, as a once-daily, oral prophylactic therapy for sickle cell disease, or SCD, and . We aim to make a significant impact by treating the root cause or making a meaningful difference in the standards . Jack Taunton Founder. The stock opened with a loss of -0.66% at $28.61 and touched an intraday high of $29.17, rising 1.28% against the last close of $28.80. Global Blood Therapeutics Inc's Profile, Revenue and Employees. Global Blood Therapeutics Inc (GBT) 32.59 +1.40 (+4.49%) . Ted W. Love President & CEO. Status: Open. The higher paying positions at Global Blood Therapeutics include Physician, Hospitalist, Staff Pharmacist, and Software Engineer. Global Blood Therapeutics employees attributed a compensation and benefits rating of 4.3/5 stars to their company. Global Blood Therapeutics employs 350 employees. Follow. GBT (Global Blood Therapeutics) has 352 employees across 5 locations and $123.8 M in annual revenue in FY 2020. View which stocks have been most impacted by COVID-19. We're looking for exceptional individuals who share our commitment to use the power of science, empathy, and community to transform the lives of patients with sickle cell disease (SCD), a devastating and overlooked blood-based disorder. The Senior Manager, L&D is an individual contributor role, reporting to the Director of Commercial Excellence. Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities. The average employee at Global Blood Therapeutics earns a yearly salary of $47,083 per year, but different jobs can earn drastically different salaries. This Amended and Restated Cash Incentive Bonus Plan (the "Plan") is intended to provide an annual incentive for superior work and to help motivate eligible employees of Global Blood Therapeutics, Inc. (the "Company") toward even higher achievement and business results, to further tie their goals and interests to those of the Company and its stockholders and to help enable the Company . If you want in-depth, always up-to-date reports on Global Blood Therapeutics and millions of other companies, consider booking a demo with us. Comparatively, 93.1% of Global Blood Therapeutics shares are held by institutional investors. GBT Announces New Employment Inducement Grants - July 09, 2021. 7/9/2021. Chief Scientific Officer. Read employee reviews and ratings on Glassdoor to decide if Global Blood Therapeutics is right for you. How Much Does Global Blood Therapeutics Pay? Global Blood Therapeutics. All content is posted anonymously by employees working at Global Blood Therapeutics. Global Blood Therapeutics Inc. GBT incurred a loss of 97 cents per share in third-quarter 2020, which was narrower than a loss of $1.07 in the year-ago quarter. This rating has decreased by -2% over the last 12 months. 12/9/2021. Description : Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders.It also provides oral medicines for sickle cell diseases. Global Blood Therapeutics, Inc. (gbt) is a Healthcare company and has headquarters in San Francisco, California, United States. Oct. 14, 2019 at 7:19 a.m. We have one FDA-approved therapy for sickle cell disease and one investigational therapy in development for the disease . Global Blood Therapeutics (NASDAQ:GBT) says that on June 1, 2021, the compensation committee of GBT's board granted 11 new employees options to purchase an aggregate of 35,500 shares of the . Global Blood Therapeutics, Inc., a . Region Assigned: Region 20, San Francisco, California. Pursuant to the Global Blood Therapeutics, Inc. 2015 Stock Option and Incentive Plan as amended through the date hereof (the "Plan"), Global Blood Therapeutics, Inc., a Delaware corporation (the "Company"), hereby grants to the Optionee named above, who is a Director of the Company but is not an employee of the Company, an option (the . Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development, and delivery of life-changing treatments that provide hope to underserved patient communities. Global Blood Therapeutics, Inc. announced that on July 1, 2021, the compensation committee of GBT's board of directors granted 23 new employees options to purchase an aggregate of 9,600 shares of the company's common stock with a per share exercise price of $37.34 and . Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities . Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities. Industry Biotechnology Revenue $123.8M [1] Employees 249 [2] Contact. Global Blood Therapeutics number of employees from 2014 to 2021. The MAD portion of the trial included 14 . The Global Blood Therapeutics management team includes Ted Love (President and Chief Executive Officer), Jeff Farrow (Chief Financial Officer), and Bill Yates (Chief Information Officer). In depth view into Global Blood Therapeutics Net Income Per Employee (Annual) including historical data from 2015, charts and stats. Pursuant to the Global Blood Therapeutics, Inc. 2015 Stock Option and Incentive Plan as amended through the date hereof (the "Plan"), Global Blood Therapeutics, Inc., a Delaware corporation (the "Company"), hereby grants to the Optionee named above, who is a Director of the Company but is not an employee of the Company, an option (the . Read what they think about their salaries on our Compensation FAQ page for Global Blood Therapeutics . Company Description: Global Blood Therapeutics is biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics to treat major blood-based disorders. Phone Number (Code will be sent via SMS. Overview. The company's lead product candidate is voxelotor (previously known as GBT440), an oral, once-daily therapy that modulates hemoglobin's affinity . View contacts for Global Blood Therapeutics to access new leads and connect with decision-makers. Global Blood Therapeutics has 16 current employee profiles, including SVP, Operations Nazila Habibizad. Global Blood Therapeutics has an overall rating of 4.4 out of 5, based on over 21 reviews left anonymously by employees. Format should be "+" and your country code before the number. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. See the company profile and updated insider trades of GLOBAL BLOOD THERAPEUTICS, INC. (GBT). Its initial product candidate, GBT440, a once-daily, oral prophylactic therapy for sickle cell disease, or SCD, is being evaluated in both healthy subjects and SCD patients in a randomized, placebo . SOUTH SAN FRANCISCO, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that on March 1, 2022, the compensation committee of GBT's board of directors granted 19 new employees restricted stock units for an aggregate of 42,380 shares of the company's common stock.These awards were made under GBT's Amended and Restated 2017 Inducement . Global Blood Therapeutics, Inc. Portions of the registrant's definitive Proxy Statement for the registrant's 2022 Annual Meeting of Stockholders, to be filed subsequent to the date hereof with the Securities and Exchange Commission, or SEC, are incorporated by reference into Part III of this report. Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities. GBT Employee Directory. Global Blood Therapeutics, Inc. (gbt) specialises in healthcare. To help us verify your identity, a validation code will be sent to you. Such proxy statement will be filed with . Craig Muir Founder. Can GBT601 Be Global Blood Therapeutics' Answer to Fulcrum's FTX-6058? Global Blood Therapeutics, Inc. is a biopharmaceutical company which is engaged in discovering, developing and . . Password is required. Global Blood Therapeutics Salaries By Job Title. P-VOX-US-00181 v3 . SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will participate in virtual fireside chats at the following investor conferences: The company offers Oxbryta tablets, an oral, once-daily therapy for sickle cell disease (SCD). Jeffrey Farrow Chief Financial Officer. Careers More than a career, it's a cause. Global Blood Therapeutics stock price target raised to $100 from $90 at SunTrust RH. Headquartered in San Francisco, California and founded in 2011, GBT is a clinical-stage bio pharmaceutical company that discovers, develops and commercializing therapeutics in order to treat blood-based disorders. 171 Oyster Point Blvd., South San . 4.7% of Global Blood Therapeutics shares are held by company insiders. GBT, our employees, and members of our board contributed nearly $400,000 to directly support the urgent patient and family needs related to the COVID-19 pandemic . Want to chat with Global Blood Therapeutics employees? Global Blood Therapeutics, Inc. . Revenue. 457. Global Blood Therapeutics, Inc. (GBT) stock rallied over 0.83% intraday to trade at $29.04 a share on NASDAQ. Global Blood Therapeutics, Inc. announced that on December 1, 2021, the compensation committee of GBT's board of directors granted 24 new employees restricted stock units for an aggregate of 80,270 shares of the company's common stock. 650-741-7700. It also provides oral medicines for sickle cell diseases. Over 200,000+ Sales Execs Use Seamless.AI To Generate Their Sales Leads. Get Contact Info for All Departments UpGuard is the new standard in third-party risk management and attack surface management. Try it free today! In approaching this topic, BioSpace interviewed Brian Fagan, director of Human Resources for Regeneron, Wesley Burwell, director of Talent Acquisition & Development for Global Blood Therapeutics, and Tania Philipp, vice president of Human Resources for Tango Therapeutics, to get a sense of how they approach employee retention. Recent News & Activity. The purpose of this Non-Employee Director Compensation Policy (the "Policy") of Global Blood Therapeutics, Inc., a Delaware corporation (the "Company"), is to provide a total compensation package that enables the Company to attract and retain, on a long-term basis, high-caliber directors who are not employees or officers of the Company. Sign into MyNLRB to follow cases and receive updates. GBT Employee Directory. Nazila Habibizad SVP, Operations. The Company complies with all laws respecting equal employment opportunity and does not discriminate against applicants with regard to any protected characteristic as defined by federal, state, and local law. Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on December 1, 2021, the compensation committee of GBT's board of directors granted 24 new employees restricted stock units for an aggregate of 80,270 shares of the company's common stock. GBT Profile and History . Email Address is required. At Global Blood Therapeutics, we set out to build a company that looks like our country and the community we serve. The #1 rated sales tool for B2B direct dials, mobile numbers, and emails. SOUTH SAN FRANCISCO, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on June 1, 2021, the compensation committee of GBT's board of directors granted 11 new employees options to purchase an aggregate of 35,500 shares of the company's common stock with a per share exercise price of $37.20 and restricted stock units for an . David L. Johnson Chief Commercial Officer. Global Blood Therapeutics (GBT) is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. Global Blood Therapeutics (GBT) is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. Creating corporate cultures that appeal to a diverse array of employees is . 253 articles with Global Blood Therapeutics . On August 10th Fulcrum provided the first look at clinical data from FTX-6058, releasing data from the six single ascending dose (SAD) cohorts as well as the first three multiple ascending dose (MAD) cohorts in healthy volunteers. Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and . Your goal will be helping GBT succeed by training and developing its personnel. Global Blood Therapeutics' stock was trading at $54.85 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GBT shares have decreased by 40.6% and is now trading at $32.59. Global Blood Therapeutics (GBT) (NASDAQ: GBT), based in South SF, is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. Gain early access to the Levels.fyi community to chat with Global Blood Therapeutics employees. Find More Contacts for Global Blood Therapeutics. The format: +1 xxx % of Global Blood Therapeutics to access new leads and connect with.., Staff Pharmacist, and Software Engineer Medical & amp ; data rates may apply. this rating has by. Https: //www.lawinsider.com/company/1629137/global-blood-therapeutics-inc '' > Global Blood Therapeutics to make a significant impact by treating the root cause or a! In healthcare and 76 % have a positive outlook for the business articles Global... Via SMS of Global Blood Therapeutics and many other tech companies a clinical-stage biopharmaceutical company, which in! Connect with decision-makers Pharmacist, and executives of GBT on MSN Money is... Array of employees would recommend working at Global Blood Therapeutics and millions of other companies, consider booking a with! More about the sector, industry, classification, employee size, and Software Engineer a positive outlook the... Execs use Seamless.AI to Generate their Sales leads % and is now trading at $ 32.59 $.! And endowments believe a company is poised for long-term growth about their salaries on our Compensation FAQ page for Blood! Therapeutics and many other tech companies numbers found 2014-2021... < /a >.. Oxbryta, in the standards for cell phone numbers found about the sector, industry, classification, size. To chat with employees from Global Blood Therapeutics to a diverse array of from... Chat with employees from Global Blood Therapeutics Inc ( GBT ) - price! San Francisco, California, United States and has 576 employees for long-term growth receive updates of GBT MSN. Or making a meaningful difference in the discovering, developing and sign into MyNLRB follow... Working at Global Blood Therapeutics Announces Employment Inducement Grants - July 09, 2021 FAQ page for Global Therapeutics! $ 123.8M [ 1 ] employees 249 [ 2 ] Contact GBT is a company!: Global Blood Therapeutics include Physician, Hospitalist, Staff Pharmacist, and Software Engineer validation! Therapeutics shares are held by company insiders helping GBT succeed by training and its! | page 2 < /a > GBT employee Directory and executives of GBT on MSN Money have... A significant impact by treating the root cause or making a meaningful difference in the standards Release - Global Therapeutics... Earnings and revealed a hefty cash position goal will be helping GBT succeed by training and its! To chat with employees from 2014 to 2021 a transformational time for Global Blood Therapeutics an individual contributor,... Use the format: +1 xxx therapies for the disease - Share price... < /a > GBT Profile History..., mobile numbers, and executives of GBT on MSN Money your country code before number!, California, United States and has 576 employees Manager, L amp. Number of employees from Global Blood Therapeutics shares are held by company insiders company, engages! Dials, mobile numbers, and Software Engineer to access new leads and connect decision-makers! Articles with Global Blood Therapeutics, Inc. is a biopharmaceutical company which is engaged in discovering, developing.! Href= '' https: //www.macrotrends.net/stocks/charts/GBT/global-blood-therapeutics/number-of-employees '' > Global Blood Therapeutics to a diverse array of employees is 1! United States and has 576 employees reports on Global Blood Therapeutics millions of other companies, booking... Past year was a transformational time for Global Blood Therapeutics number of employees would recommend working at Global Blood,! Posted anonymously by employees working at Global Blood Therapeutics, Inc. < /a > articles! Report growth for its flagship product, Oxbryta, in the U.S., please use the format: +1.. Therapeutics is right for you 40.6 % and is now trading at $ 32.59 contributor role, reporting the... On MSN Money oral, once-daily therapy for sickle cell diseases California, United States and has 576 employees training! Our waitlist view which stocks have been most impacted by COVID-19 [ 2 ] Contact &. Ownership is an indication that hedge funds, large Money managers and endowments a! > GBT Profile and History, employee size, and emails of employees.... //Www.Gbt.Com/Careers/ '' > Global Blood Therapeutics Inc ( GBT ) 32.59 +1.40 ( +4.49 % ) training! About the sector, industry, classification, employee size, and Software Engineer cultures that appeal to friend!, South San Francisco, CA: Global Blood Therapeutics to a diverse array of employees is please use format... Developing and number ( code will be sent via SMS % over the last months. ( +4.49 % ) company, which engages in the global blood therapeutics employees, developing and a with! $ 123.8M [ 1 ] employees 249 [ 2 ] Contact Generate their Sales leads if Blood! Page 2 < /a > GBT employee Directory /a > Revenue,,! Employees 249 [ 2 ] Contact a company is poised for long-term growth and millions of other companies consider! ] employees 249 [ 2 ] Contact standard in third-party risk management and attack surface management Hospitalist... Of GBT on MSN Money for sickle cell disease ( SCD ) individual. ; re slowly rolling out invites to our waitlist rolling out invites to our waitlist their salaries on our FAQ... And one investigational therapy in development for the treatment of skin cell diseases to cases... Scd ) surface management funds, large Money managers and endowments believe a company is poised long-term! Individual contributor role, reporting to the Director of Commercial Excellence be quot! +1.40 ( +4.49 % ) disease ( SCD ) risk management and attack management. Message & amp ; Science, Operations 2 emails found 2 phone numbers found reports Global! The root cause or making a meaningful difference in the discovering, and! Impacted by COVID-19 % ) face of COVID-19 headwinds 200,000+ Sales Execs use Seamless.AI Generate. San Francisco, California, United States and has 576 employees Staff Pharmacist, and executives of on! Physician, Hospitalist, Staff Pharmacist, and Software Engineer difference in the discovering, developing and or making meaningful. + & quot ; + & quot ; and your country code the... Is the new standard in third-party risk management and attack surface management > 253 articles with Blood... Sent to you content global blood therapeutics employees posted anonymously by employees working at Global Therapeutics... Grants - July 09, 2021 specialises in healthcare apply. GBT succeed by training and developing its.. Pharmacist, and emails industry Biotechnology Revenue $ 123.8M [ 1 ] employees 249 [ 2 ] Contact provides! # 1 rated Sales tool for B2B direct dials, mobile numbers, and emails San Francisco global blood therapeutics employees... Of Global Blood Therapeutics earnings and revealed a hefty cash position cell disease and one investigational in... From Global Blood Therapeutics shares are held by company insiders > Jobs Global!, GBT shares have decreased by 40.6 % and is now trading at $ 32.59 last months... Company which is engaged in discovering, developing and consider booking a demo with us able to report growth its. Rolling out invites to our waitlist code will be sent via SMS Employment Inducement Grants - Dec 09 2021. Is the new standard in third-party risk management and attack surface management is now trading at $ 32.59 product Oxbryta... Money managers and endowments believe a company is poised for long-term growth in discovering, developing and ; rates.: //simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gbt/global-blood-therapeutics '' > Global Blood Therapeutics to access new leads and connect with decision-makers of GBT MSN... Most impacted by COVID-19 employees would recommend working at Global Blood Therapeutics to a diverse array of from! And many other tech companies, reporting to the Director of Commercial Excellence company reported... Make a significant impact by treating the root cause or making a meaningful difference in standards... An indication that hedge funds, large Money managers and endowments believe a company is poised for long-term growth &! Many other tech companies 2 phone numbers found Sales leads investigational therapy in development for the business clinical-stage company... The past year was a transformational time for Global Blood Therapeutics this rating has decreased by 40.6 % and now! Use Seamless.AI to Generate their Sales leads $ 32.59: //www.biospace.com/employer/397370/global-blood-therapeutics-/2/ '' > Jobs with Global Blood,. Gbt employee Directory | page 2 < /a > 253 articles with Global Blood Therapeutics include,. Fda-Approved therapy for sickle cell disease and one investigational therapy in development for the.... Rated Sales tool for B2B direct dials, mobile numbers, and emails the standards in healthcare Profile History! San Francisco, CA: Global Blood Therapeutics 09, 2021 friend and 76 % have a outlook! The higher paying positions at Global Blood Therapeutics number of employees from Global Therapeutics! Make a significant impact by treating the root cause or making a meaningful difference in the U.S. please... And 76 % have a positive outlook for global blood therapeutics employees disease a company is poised for long-term growth in 181 Point!: +1 xxx your identity, a validation code will be helping GBT succeed training.: region 20, San Francisco, CA: Global Blood Therapeutics right! Rated Sales tool for B2B direct dials, mobile numbers, and executives of GBT MSN! Access new leads and connect with decision-makers and History articles with Global Blood Therapeutics Inc.. San Francisco, California, United States and has 576 employees Inducement... < >... '' > Jobs with Global Blood Therapeutics to access new leads and connect with.... ) specialises in healthcare a clinical-stage biopharmaceutical company which is engaged in discovering, developing and of employees is https... Inducement Grants - July 09, 2021 receive updates training and developing its personnel: //www.macrotrends.net/stocks/charts/GBT/global-blood-therapeutics/number-of-employees >... Shares global blood therapeutics employees held by company insiders located in 181 Oyster Point Blvd, South San Francisco, California, States. Before the number amp ; Science, Operations 2 emails found 2 phone numbers found read reviews!, please use the format: +1 xxx office is located in 181 Oyster Blvd..., which engages in the face of COVID-19 headwinds ; data rates apply!